Literature DB >> 7371698

Inhibition by idrocilamide of the disposition of caffeine.

J L Brazier, J Descotes, N Lery, M Ollagnier, J C Evreux.   

Abstract

The pharmacokinetics of caffeine are greatly altered by concomitant administration of idrocilamide. In four healthy volunteers id rocilamide inhibited the biotransformation of caffeine and increased its half-life nine times. The untoward neuropsychiatric effects of idrocilamide are the consequence of abnormal accumulation of caffeine in regular consumers of caffeine-containing foods and beverages.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7371698     DOI： 10.1007/bf00561675

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  5 in total

1.  A study of the metabolism of theobromine, theophylline, and caffeine in man.

Authors:  H H CORNISH; A A CHRISTMAN
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

2.  [Letter: Unusual neuropsychic effects due to idrocilamide].

Authors:  N Lery; J C Evreux; E Schwam; H Laisne
Journal:  Nouv Presse Med       Date:  1976-02-28

3.  [Influence of tobacco smoking on caffeine pharmacokinetics (author's transl)].

Authors:  J Descotes; J L Brazier; M Ollagnier; J C Evreux
Journal:  Therapie       Date:  1979 Sep-Oct       Impact factor: 2.070

4.  The human metabolism of caffeine to theophylline.

Authors:  S Sved; R D Hossie; I J McGilveray
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-02

5.  Effect of smoking on caffeine clearance.

Authors:  W D Parsons; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875
  5 in total
  9 in total

1.  Rapid and sensitive gas-chromatographic determination of caffeine in blood plasma, saliva, and xanthine beverages.

Authors:  H W Teeuwen; E L Elbers; J M van Rossum
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

2.  Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.

Authors:  Laurence Gabriel; Michel Tod; Sylvain Goutelle
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

3.  Accumulation of caffeine in healthy volunteers treated with furafylline.

Authors:  E Tarrus; J Cami; D J Roberts; R G Spickett; E Celdran; J Segura
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  Factors influencing the caffeine test for cytochrome P 448-dependent liver function.

Authors:  R Joeres; H Klinker; H Huesler; J Epping; G Hofstetter; D Drost; H Reuss; W Zilly; E Richter
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

5.  Comparison of the urinary metabolite profile of caffeine in young and elderly males.

Authors:  J Blanchard; S J Sawers; J H Jonkman; D D Tang-Liu
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

Review 6.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

7.  Interaction between oral ciprofloxacin and caffeine in normal volunteers.

Authors:  D P Healy; R E Polk; L Kanawati; D T Rock; M L Mooney
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

8.  Decreased systemic clearance of caffeine due to cimetidine.

Authors:  L J Broughton; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

Review 9.  Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Authors:  Jan Grzegorzewski; Florian Bartsch; Adrian Köller; Matthias König
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.